4//SEC Filing
O'Hara Elaine 4
Accession 0001593968-25-000303
CIK 0001000694other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:02 PM ET
Size
7.9 KB
Accession
0001593968-25-000303
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
O'Hara Elaine
EVP, Chief Strategy Officer
Transactions
- Award
2025 Non-statutory Stock Option NQ
2025-03-03$7.87/sh+253,500$1,995,045→ 253,500 totalExercise: $7.87Exp: 2035-03-03→ Common Stock (253,500 underlying) - Award
2025 Restricted Stock Units RSU
2025-03-03+169,000→ 169,000 totalExercise: $0.00Exp: 2035-03-03→ Common Stock (169,000 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- [F2]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001968045
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:02 PM ET
- Size
- 7.9 KB